The DOI matches its Crossref record; 131 of the 131 references it cites were found in a registry or an index.
The Global Landscape of EBV-Associated Tumors
Open accessAbstract
Epstein-Barr virus (EBV), a gamma-1 herpesvirus, is carried as a life-long asymptomatic infection by the great majority of individuals in all human populations. Yet this seemingly innocent virus is aetiologically linked to two pre-malignant lymphoproliferative diseases (LPDs) and up to nine distinct human tumours; collectively these have a huge global impact, being responsible for some 200,000 new cases of cancer arising worldwide each year. EBV replicates in oral epithelium but persists as a latent infection within the B cell system and several of its diseases are indeed of B cell origin; these include B-LPD of the immunocompromised, Hodgkin Lymphoma (HL), Burkitt Lymphoma (BL), Diffuse Large B cell Lymphoma (DLBCL) and two rarer tumours associated with profound immune impairment, plasmablastic lymphoma (PBL) and primary effusion lymphoma (PEL). Surprisingly, the virus is also linked to tumours arising in other cellular niches which, rather than being essential reservoirs of virus persistence in vivo, appear to represent rare cul-de-sacs of latent infection. These non-B cell tumours include LPDs and malignant lymphomas of T or NK cells, nasopharyngeal carcinoma (NPC) and gastric carcinoma of epithelial origin, and leiomyosarcoma, a rare smooth muscle cell tumour of the immunocompromised. Here we describe the main characteristics of these tumours, their distinct epidemiologies, histological features and degrees of EBV association, then consider how their different patterns of EBV latency may reflect the alternative latency programmes through which the virus first colonises and then persists in immunocompetent host. For each tumour, we discuss current understanding of EBV’s role in the oncogenic process, the identity (where known) of host genetic and environmental factors predisposing tumour development, and the recent evidence from cancer genomics identifying somatic changes that either complement or in some cases replace the contribution of the virus. Thereafter we look for possible connections between the pathogenesis of these apparently different malignancies and point to new research areas where insights may be gained.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
Swerdlow, S. H., Campo, E., Pileri, S. A., Harris, N. L., Stein, H., Siebert, R., Advani, R., Ghielmini, M., Salles, G. A., Zelenetz, A. D., et al. (2016) · Blood · doi:10.1182/blood-2016-01-643569 · Cited by 7,831
Comprehensive molecular characterization of gastric adenocarcinoma
The Cancer Genome Atlas Research Network (2014) · Nature · doi:10.1038/nature13480 · Cited by 6,498
The global health burden of infection‐associated cancers in the year 2002
Parkin, D. M. (2006) · International Journal of Cancer · doi:10.1002/ijc.21731 · Cited by 2,932
VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA
Epstein, M. A., Achong, B. G., & Barr, Y. M. (1964) · The Lancet · doi:10.1016/s0140-6736(64)91524-7 · Cited by 2,778
Global burden of cancers attributable to infections in 2008: a review and synthetic analysis
de Martel, C., Ferlay, J., Franceschi, S., Vignat, J., Bray, F., Forman, D., & Plummer, M. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70137-7 · Cited by 2,534
Epstein–Barr virus: 40 years on
Young, L. S., & Rickinson, A. B. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1452 · Cited by 2,227
Self-citationA sarcoma involving the jaws in african children
Burkitt, D. (1958) · Journal of British Surgery · doi:10.1002/bjs.18004619704 · Cited by 1,323
The Enigmatic Epidemiology of Nasopharyngeal Carcinoma
Chang, E. T., & Adami, H.-O. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0353 · Cited by 1,297
Rooney, C. M., Ng, C. Y. C., Loftin, S., Smith, C. A., Li, C., Krance, R. A., Brenner, M. K., Heslop, H. E., Rooney, C. M., Brenner, M. K., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91150-2 · Cited by 1,173
Detection of Epstein–Barr Viral Genomes in Reed–Sternberg Cells of Hodgkin's Disease
Weiss, L. M., Movahed, L. A., Warnke, R. A., & Sklar, J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198902233200806 · Cited by 886
EBV Persistence in Memory B Cells In Vivo
Babcock, G. J., Decker, L. L., Volk, M., & Thorley-Lawson, D. A. (1998) · Immunity · doi:10.1016/s1074-7613(00)80622-6 · Cited by 825
Greenspan, J. S., Greenspan, D., Lennette, E. T., Abrams, D. I., Conant, M. A., Petersen, V., & Freese, U. K. (1985) · New England Journal of Medicine · doi:10.1056/nejm198512193132502 · Cited by 805
Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer
Wang, K., Kan, J., Yuen, S. T., Shi, S. T., Chu, K. M., Law, S., Chan, T. L., Kan, Z., Chan, A. S. Y., Tsui, W. Y., et al. (2011) · Nature Genetics · doi:10.1038/ng.982 · Cited by 771
Spread of HTLV-I Between Lymphocytes by Virus-Induced Polarization of the Cytoskeleton
Igakura, T., Stinchcombe, J. C., Goon, P. K. C., Taylor, G. P., Weber, J. N., Griffiths, G. M., Tanaka, Y., Osame, M., & Bangham, C. R. M. (2003) · Science · doi:10.1126/science.1080115 · Cited by 755
Why do viruses cause cancer? Highlights of the first century of human tumour virology
Moore, P. S., & Chang, Y. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2961 · Cited by 745
Küppers, R., Rajewsky, K., Zhao, M., Simons, G., Laumann, R., Fischer, R., & Hansmann, M. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.10962 · Cited by 672
Association of Epstein–Barr Virus with Leiomyosarcomas in Young People with AIDS
McClain, K. L., Leach, C. T., Jenson, H. B., Joshi, V. V., Pollock, B. H., Parmley, R. T., DiCarlo, F. J., Chadwick, E. G., & Murphy, S. B. (1995) · New England Journal of Medicine · doi:10.1056/nejm199501053320103 · Cited by 627
Epstein–Barr virus infection and nasopharyngeal carcinoma
Tsao, S. W., Tsang, C. M., & Lo, K. W. (2017) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2016.0270 · Cited by 606
The Immunology of Epstein-Barr Virus–Induced Disease
Taylor, G. S., Long, H. M., Brooks, J. M., Rickinson, A. B., & Hislop, A. D. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112326 · Cited by 602
Self-citationCaldwell, R. G., Wilson, J. B., Anderson, S. J., & Longnecker, R. (1998) · Immunity · doi:10.1016/s1074-7613(00)80623-8 · Cited by 597
Dojcinov, S. D., Venkataraman, G., Raffeld, M., Pittaluga, S., & Jaffe, E. S. (2010) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181cf8622 · Cited by 571
Laichalk, L. L., & Thorley-Lawson, D. A. (2005) · Journal of Virology · doi:10.1128/jvi.79.2.1296-1307.2005 · Cited by 538
B cells under influence: transformation of B cells by Epstein–Barr virus
Küppers, R. (2003) · Nature Reviews Immunology · doi:10.1038/nri1201 · Cited by 529
Germinal centres and B cell lymphomagenesis
Basso, K., & Dalla-Favera, R. (2015) · Nature Reviews Immunology · doi:10.1038/nri3814 · Cited by 510
Bollard, C. M., Gottschalk, S., Torrano, V., Diouf, O., Ku, S., Hazrat, Y., Carrum, G., Ramos, C., Fayad, L., Shpall, E. J., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.51.5304 · Cited by 503
Murphy, G., Pfeiffer, R., Camargo, M. C., & Rabkin, C. S. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.05.001 · Cited by 500
Hodgkin lymphoma: A review and update on recent progress
Shanbhag, S., & Ambinder, R. F. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21438 · Cited by 481
Hsu, C., Lee, S.-H., Ejadi, S., Even, C., Cohen, R. B., Le Tourneau, C., Mehnert, J. M., Algazi, A., van Brummelen, E. M. J., Saraf, S., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.73.3675 · Cited by 464
Ma, B. B. Y., Lim, W.-T., Goh, B.-C., Hui, E. P., Lo, K.-W., Pettinger, A., Foster, N. R., Riess, J. W., Agulnik, M., Chang, A. Y. C., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.77.0388 · Cited by 451
JONES, J. F., RAY, C. G., MINNICH, L. L., HICKS, M. J., KIBLER, R., & LUCAS, D. O. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-102-1- · Cited by 446
Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS
Biggar, R. J., Jaffe, E. S., Goedert, J. J., Chaturvedi, A., Pfeiffer, R., Engels, E. A., & Study, F. T. H. C. M. (2006) · Blood · doi:10.1182/blood-2006-05-024109 · Cited by 436
Epstein–Barr virus-associated lymphomas
Shannon-Lowe, C., Rickinson, A. B., & Bell, A. I. (2017) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2016.0271 · Cited by 428
Self-citationSenile EBV+ B-Cell Lymphoproliferative Disorders: A Clinicopathologic Study of 22 Patients
Oyama, T., Ichimura, K., Suzuki, R., Suzumiya, J., Ohshima, K., Yatabe, Y., Yokoi, T., Kojima, M., Kamiya, Y., Taji, H., et al. (2003) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200301000-00003 · Cited by 394
Epstein-Barr Virus: An Important Vaccine Target for Cancer Prevention
Cohen, J. I., Fauci, A. S., Varmus, H., & Nabel, G. J. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002878 · Cited by 381
Exome sequencing identifies somatic mutations of DDX3X in natural killer/T-cell lymphoma
Jiang, L., Gu, Z.-H., Yan, Z.-X., Zhao, X., Xie, Y.-Y., Zhang, Z.-G., Pan, C.-M., Hu, Y., Cai, C.-P., Dong, Y., et al. (2015) · Nature Genetics · doi:10.1038/ng.3358 · Cited by 366
HIV-associated lymphomas and gamma-herpesviruses
Carbone, A., Cesarman, E., Spina, M., Gloghini, A., & Schulz, T. F. (2008) · Blood · doi:10.1182/blood-2008-09-180315 · Cited by 354
de Martel, C., Forman, D., & Plummer, M. (2013) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2013.01.003 · Cited by 338
EBV Persistence—Introducing the Virus
Thorley-Lawson, D. A. (2015) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-319-22822-8_8 · Cited by 333
Epstein–Barr Virus Infection and Posttransplant Lymphoproliferative Disorder
Green, M., & Michaels, M. G. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12004 · Cited by 325
Shibata, D. K., Tokunaga, M., Uemura, Y., Sato, E., Tanaka, S., & Weiss, L. M. (1991) · PubMed · Cited by 317
Tsai, C.-N., Tsai, C.-L., Tse, K.-P., Chang, H.-Y., & Chang, Y.-S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152059399 · Cited by 315
Presence of EB Virus Nucleic Acid Homology in a “Virus-free” Line of Burkitt Tumour Cells
HAUSEN, H. Z., & SCHULTE-HOLTHAUSEN, H. (1970) · Nature · doi:10.1038/227245a0 · Cited by 312
Exome and genome sequencing of nasopharynx cancer identifies NF-κB pathway activating mutations
Li, Y. Y., Chung, G. T. Y., Lui, V. W. Y., To, K.-F., Ma, B. B. Y., Chow, C., Woo, J. K., Yip, K. Y., Seo, J., Hui, E. P., et al. (2017) · Nature Communications · doi:10.1038/ncomms14121 · Cited by 309
Kikuta, H., Taguchi, Y., Tomizawa, K., Kojima, K., Kawamura, N., Ishizaka, A., Sakiyama, Y., Matsumoto, S., Imai, S., Kinoshita, T., et al. (1988) · Nature · doi:10.1038/333455a0 · Cited by 281
Grande, B. M., Gerhard, D. S., Jiang, A., Griner, N. B., Abramson, J. S., Alexander, T. B., Allen, H., Ayers, L. W., Bethony, J. M., Bhatia, K., et al. (2019) · Blood · doi:10.1182/blood-2018-09-871418 · Cited by 270
Genetic and epigenetic changes in nasopharyngeal carcinoma
Lo, K.-W., & Huang, D. P. (2002) · Seminars in Cancer Biology · doi:10.1016/s1044579x02000883 · Cited by 269
Lee, J., Kim, S., Han, S., An, J., Lee, E., & Kim, Y. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.05775.x · Cited by 256
Wang, L., Chang, E. W. Y., Wong, S. C., Ong, S.-M., Chong, D. Q. Y., & Ling, K. L. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202088 · Cited by 251
Xu, M., Yao, Y., Chen, H., Zhang, S., Cao, S.-M., Zhang, Z., Luo, B., Liu, Z., Li, Z., Xiang, T., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0436-5 · Cited by 249
Pathogenesis and Host Control of Gammaherpesviruses: Lessons from the Mouse
Barton, E., Mandal, P., & Speck, S. H. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-072710-081639 · Cited by 246
Activation of DNA Methyltransferase 1 by EBV LMP1 Involves c-Jun NH2-Terminal Kinase Signaling
Tsai, C.-L., Li, H.-P., Lu, Y.-J., Hsueh, C., Liang, Y., Chen, C.-L., Tsao, S. W., Tse, K.-P., Yu, J.-S., & Chang, Y.-S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2194 · Cited by 245
Oncogenic Mechanisms in Burkitt Lymphoma
Schmitz, R., Ceribelli, M., Pittaluga, S., Wright, G., & Staudt, L. M. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014282 · Cited by 245
Defective Epstein–Barr virus in chronic active infection and haematological malignancy
Okuno, Y., Murata, T., Sato, Y., Muramatsu, H., Ito, Y., Watanabe, T., Okuno, T., Murakami, N., Yoshida, K., Sawada, A., et al. (2019) · Nature Microbiology · doi:10.1038/s41564-018-0334-0 · Cited by 239
Post-transplant lymphoproliferative disorders
Dharnidharka, V. R., Webster, A. C., Martinez, O. M., Preiksaitis, J. K., Leblond, V., & Choquet, S. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.88 · Cited by 235
Louis, C. U., Straathof, K., Bollard, C. M., Ennamuri, S., Gerken, C., Lopez, T. T., Huls, M. H., Sheehan, A., Wu, M.-F., Liu, H., et al. (2010) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181f3cbf4 · Cited by 231
Kelly, G., Bell, A., & Rickinson, A. (2002) · Nature Medicine · doi:10.1038/nm758 · Cited by 228
Self-citationEBV-Infected B Cells in Infectious Mononucleosis
Kurth, J., Spieker, T., Wustrow, J., Strickler, J. G., Hansmann, M.-L., Rajewsky, K., & Küppers, R. (2000) · Immunity · doi:10.1016/s1074-7613(00)00048-0 · Cited by 226
Epstein-Barr Virus Lytic Infection Contributes to Lymphoproliferative Disease in a SCID Mouse Model
Hong, G. K., Gulley, M. L., Feng, W.-H., Delecluse, H.-J., Holley-Guthrie, E., & Kenney, S. C. (2005) · Journal of Virology · doi:10.1128/jvi.79.22.13993-14003.2005 · Cited by 225
Resting B cells as a transfer vehicle for Epstein–Barr virus infection of epithelial cells
Shannon-Lowe, C. D., Neuhierl, B., Baldwin, G., Rickinson, A. B., & Delecluse, H.-J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510512103 · Cited by 206
Self-citationEpstein–Barr Virus Infection as an Epigenetic Driver of Tumorigenesis
Kaneda, A., Matsusaka, K., Aburatani, H., & Fukayama, M. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3919 · Cited by 204
Molecular biology of Hodgkin's and Reed/Sternberg cells in Hodgkin's lymphoma
Bräuninger, A., Schmitz, R., Bechtel, D., Renné, C., Hansmann, M., & Küppers, R. (2006) · International Journal of Cancer · doi:10.1002/ijc.21716 · Cited by 202
Epstein‐Barr virus strain variation and cancer
Kanda, T., Yajima, M., & Ikuta, K. (2019) · Cancer Science · doi:10.1111/cas.13954 · Cited by 197
Epidemiology: clues to the pathogenesis of Burkitt lymphoma
Magrath, I. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.09013.x · Cited by 195
Rowe, M., Khanna, R., Jacob, C. A., Argaet, V., Kelly, A., Powis, S., Belich, M., Groom‐Carter, D., Lee, S., Burrows, S. R., et al. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250536 · Cited by 191
Self-citationPatterns of Epstein-Barr virus infection in non-neoplastic lymphoid tissue
Niedobitek, G., Herbst, H., Young, L., Brooks, L., Masucci, M., Crocker, J., Rickinson, A., & Stein, H. (1992) · Blood · doi:10.1182/blood.v79.10.2520.2520 · Cited by 190
Self-citationCo-infections, inflammation and oncogenesis: Future directions for EBV research
Rickinson, A. B. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.04.004 · Cited by 184
Self-citationComprehensive Profiling of Epstein-Barr Virus MicroRNAs in Nasopharyngeal Carcinoma
Cosmopoulos, K., Pegtel, M., Hawkins, J., Moffett, H., Novina, C., Middeldorp, J., & Thorley-Lawson, D. A. (2009) · Journal of Virology · doi:10.1128/jvi.02104-08 · Cited by 183
The Dispersal of Mucosal Memory B Cells
Laichalk, L. L., Hochberg, D., Babcock, G. J., Freeman, R. B., & Thorley-Lawson, D. A. (2002) · Immunity · doi:10.1016/s1074-7613(02)00318-7 · Cited by 182
Zheng, H., Dai, W., Cheung, A. K. L., Ko, J. M. Y., Kan, R., Wong, B. W. Y., Leong, M. M. L., Deng, M., Kwok, T. C. T., Chan, J. Y.-W., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1607606113 · Cited by 182
Generation of memory B cells and their reactivation
Inoue, T., Moran, I., Shinnakasu, R., Phan, T. G., & Kurosaki, T. (2018) · Immunological Reviews · doi:10.1111/imr.12640 · Cited by 181
Activation of nuclear factor-kappaB p50 homodimer/Bcl-3 complexes in nasopharyngeal carcinoma.
Thornburg, N. J., Rajadurai, P., & Raab‐Traub, N. (2003) · PubMed · Cited by 179
Epstein–Barr Virus and Hemophagocytic Lymphohistiocytosis
Marsh, R. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01902 · Cited by 178
Kelly, G. L., Long, H. M., Stylianou, J., Thomas, W. A., Leese, A., Bell, A. I., Bornkamm, G. W., Mautner, J., Rickinson, A. B., & Rowe, M. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000341 · Cited by 177
Self-citationLee, S., Park, H. Y., Kang, S. Y., Kim, S. J., Hwang, J., Lee, S., Kwak, S. H., Park, K. S., Yoo, H. Y., Kim, W. S., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3776 · Cited by 174
Determinants of Epstein-Barr virus-positive gastric cancer: an international pooled analysis
Camargo, M. C., Murphy, G., Koriyama, C., Pfeiffer, R. M., Kim, W. H., Herrera-Goepfert, R., Corvalan, A. H., Carrascal, E., Abdirad, A., Anwar, M., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.215 · Cited by 173
Epstein–Barr virus maintains lymphomas via its miRNAs
Vereide, D. T., Seto, E., Chiu, Y.-F., Hayes, M., Tagawa, T., Grundhoff, A., Hammerschmidt, W., & Sugden, B. (2014) · Oncogene · doi:10.1038/onc.2013.71 · Cited by 171
EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors
White, R. E., Rämer, P. C., Naresh, K. N., Meixlsperger, S., Pinaud, L., Rooney, C., Savoldo, B., Coutinho, R., Bödör, C., Gribben, J., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58092 · Cited by 166
Cyclin D1 overexpression supports stable EBV infection in nasopharyngeal epithelial cells
Tsang, C. M., Yip, Y. L., Lo, K. W., Deng, W., To, K. F., Hau, P. M., Lau, V. M. Y., Takada, K., Lui, V. W. Y., Lung, M. L., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202637109 · Cited by 159
Epstein‐Barr virus and the pathogenesis of Burkitt's lymphoma: More questions than answers
Bornkamm, G. W. (2008) · International Journal of Cancer · doi:10.1002/ijc.24223 · Cited by 156
Primary Immunodeficiencies Associated with EBV Disease
Cohen, J. I. (2015) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-22822-8_10 · Cited by 151
Hodgkin lymphoma: Pathology and biology
Mathas, S., Hartmann, S., & Küppers, R. (2016) · Seminars in Hematology · doi:10.1053/j.seminhematol.2016.05.007 · Cited by 148
A human immunodeficiency syndrome caused by mutations in CARMIL2
Schober, T., Magg, T., Laschinger, M., Rohlfs, M., Linhares, N. D., Puchałka, J., Weißer, T., Fehlner, K., Mautner, J., Walz, C., et al. (2017) · Nature Communications · doi:10.1038/ncomms14209 · Cited by 139
Cai, T., Ye, S., Liu, Y.-N., He, J., Chen, Q.-Y., Mai, H., Zhang, C.-X., Cui, J., Zhang, X.-S., Busson, P., et al. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006503 · Cited by 138
Infection of human thymocytes by Epstein-Barr virus.
Watry, D. D., Hedrick, J. A., Siervo, S., Rhodes, G. H., Lamberti, J. J., Lambris, J. D., & Tsoukas, C. D. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.173.4.971 · Cited by 137
McHugh, D., Caduff, N., Barros, M. H. M., Rämer, P. C., Raykova, A., Murer, A., Landtwing, V., Quast, I., Styles, C. T., Spohn, M., et al. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.06.009 · Cited by 137
Loong, F., Chan, A. C. L., Ho, B. C. S., Chau, Y.-P., Lee, H. Y., Cheuk, W., Yuen, W. K., Ng, W.-S., Cheung, H.-L., & Chan, J. K. C. (2010) · Modern Pathology · doi:10.1038/modpathol.2009.168 · Cited by 131
XLP: Clinical Features and Molecular Etiology due to Mutations in SH2D1A Encoding SAP
Tangye, S. G. (2014) · Journal of Clinical Immunology · doi:10.1007/s10875-014-0083-7 · Cited by 130
Faulkner, G. C., Burrows, S. R., Khanna, R., Moss, D. J., Bird, A. G., & Crawford, D. (1999) · Journal of Virology · doi:10.1128/jvi.73.2.1555-1564.1999 · Cited by 130
Ng, S., Chung, T., Kato, S. X., Nakamura, S., Takahashi, E., Ko, Y. H., Khoury, J. D., Yin, C. C., Soong, R., Jeyasekharan, A. D. D., et al. (2017) · Haematologica · doi:10.3324/haematol.2017.180430 · Cited by 130
Molecular evolution of the γ–Herpesvirinae
McGeoch, D. J. (2001) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2000.0775 · Cited by 122
Epstein–Barr Virus Infection and Gastric Cancer
Chen, X., Chen, H., Castro, F. A., Hu, J., & Brenner, H. (2015) · Medicine · doi:10.1097/md.0000000000000792 · Cited by 120
Nijland, M., Veenstra, R. N., Visser, L., Xu, C., Kushekhar, K., Imhoff, G. W. V., Kluin, P. M., van den Berg, A., & Diepstra, A. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1295202 · Cited by 115
Tang, M., Lautenberger, J. A., Gao, X., Sezgın, E., Hendrickson, S. L., Troyer, J. L., David, V. A., Guan, L., MCINTOSH, C. E., Guo, X., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1003103 · Cited by 111
Boyer, D. F., McKelvie, P. A., de Leval, L., Edlefsen, K. L., Ko, Y. H., Aberman, Z., Kovach, A. E., Masih, A. S., Nishino, H., Weiss, L. M., et al. (2017) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000775 · Cited by 110
Chuang, H., Lay, J., Hsieh, W., Wang, H., Chang, Y., Chuang, S., & Su, I. (2005) · Blood · doi:10.1182/blood-2005-04-1406 · Cited by 105
Pegtel, D. M., Subramanian, A., Sheen, T., Tsai, C.-H. A., Golub, T. R., & Thorley‐Lawson, D. A. (2005) · Journal of Virology · doi:10.1128/jvi.79.24.15430-15442.2005 · Cited by 105
Njie, R., Bell, A. I., Jia, H., Croom-Carter, D. S. G., Chaganti, S., Hislop, A. D., Whittle, H. C., & Rickinson, A. B. (2008) · The Journal of Infectious Diseases · doi:10.1086/594373 · Cited by 105
Self-citationRomano, A., Parrinello, N. L., Vetro, C., Forte, S., Chiarenza, A., Figuera, A., Motta, G., Palumbo, G. A., Ippolito, M., Consoli, U., et al. (2014) · British Journal of Haematology · doi:10.1111/bjh.13198 · Cited by 99
Chan, A. S., To, K., Lo, K. W., et al. (2002) · International Journal of Cancer · doi:10.1002/ijc.10689 · Cited by 98
Zhang, H., Li, Z.-L., Ye, S., OuYang, L.-Y., Chen, Y.-S., He, J., Huang, H.-Q., Zeng, Y.-X., Zhang, X.-S., & Li, J. (2015) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-015-1765-6 · Cited by 97
The tumor virus landscape of AIDS-related lymphomas
Arvey, A. J., Ojesina, A. I., Pedamallu, C. S., Ballon, G., Jung, J., Duke, F. F., Leoncini, L., Falco, G. D., Bressman, E., Tam, W., et al. (2015) · Blood · doi:10.1182/blood-2014-11-599951 · Cited by 92
Marini, O., Spina, C., Mimiola, E., Cassaro, A., Malerba, G., Todeschini, G., Perbellini, O., Scupoli, M. T., Carli, G., Facchinelli, D., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8507 · Cited by 92
Castillo, J. J., Beltrán, B., Miranda, R. N., Young, K. H., Chávez, J. C., & Sotomayor, E. M. (2016) · American Journal of Hematology · doi:10.1002/ajh.24370 · Cited by 91
The Epstein-Barr Virus Encoded BART miRNAs Potentiate Tumor Growth In Vivo
Qiu, J. J., Smith, P., Leahy, L., & Thorley‐Lawson, D. A. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004561 · Cited by 89
The Long and Complicated Relationship between Epstein-Barr Virus and Epithelial Cells
Hutt‐Fletcher, L. M. (2016) · Journal of Virology · doi:10.1128/jvi.01677-16 · Cited by 87
Lymphomatoid Granulomatosis and Other Epstein-Barr Virus Associated Lymphoproliferative Processes
Dunleavy, K. M., Roschewski, M. J., & Wilson, W. H. (2012) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-012-0132-3 · Cited by 80
Epstein–Barr virus enhances genome maintenance of Kaposi sarcoma-associated herpesvirus
Bigi, R., Landis, J. T., An, H., Caro‐Vegas, C., Raab‐Traub, N., & Dittmer, D. P. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1810128115 · Cited by 76
Epstein-Barr Virus and Hodgkin Lymphoma
Ambinder, R. F. (2007) · Hematology · doi:10.1182/asheducation-2007.1.204 · Cited by 71
Allday, M. J., Bazot, Q., & White, R. E. (2015) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-22834-1_3 · Cited by 71
The Microenvironment in Epstein–Barr Virus-Associated Malignancies
Tan, G. W., Visser, L., Tan, L., van den Berg, A., & Diepstra, A. (2018) · Pathogens · doi:10.3390/pathogens7020040 · Cited by 68
Chaganti, S., Heath, E. M., Bergler, W. F., Kuo, M., Buettner, M. J., Niedobitek, G., Rickinson, A. B., & Bell, A. I. (2009) · Blood · doi:10.1182/blood-2008-08-175828 · Cited by 66
Self-citationIshida, F. (2018) · Frontiers in Pediatrics · doi:10.3389/fped.2018.00292 · Cited by 63
Fox, C. P., Shannon‐Lowe, C., Gothard, P., Kishore, B., Neilson, J. R., O’Connor, N., & Rowe, M. (2010) · Clinical Infectious Diseases · doi:10.1086/653424 · Cited by 61
Self-citationSu, W.-H., Hildesheim, A., & Chang, Y. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00299 · Cited by 59
Kushekhar, K., van den Berg, A., Nolte, I. M., Hepkema, B. G., Visser, L., & Diepstra, A. (2014) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-0683 · Cited by 59
Abé, H., Kaneda, A., & Fukayama, M. (2015) · Pathobiology · doi:10.1159/000434683 · Cited by 58
Cohen, M., Narbaitz, M., Metrebian, F., Matteo, E. D., Preciado, M. V., & Chabay, P. (2014) · International Journal of Cancer · doi:10.1002/ijc.28942 · Cited by 58
Moralès, O., Mrizak, D., François, V., Mustapha, R., Miroux, C., Depil, S., Decouvelaere, A., Lionne‐Huyghe, P., Auriault, C., de Launoit, Y., et al. (2014) · British Journal of Haematology · doi:10.1111/bjh.12980 · Cited by 58
Genetic susceptibility to the endemic form of NPC
Bei, J., Zuo, X.-Y., Liu, W.-S., Guo, Y., & Zeng, Y.-X. (2016) · Chinese Clinical Oncology · doi:10.21037/cco.2016.03.11 · Cited by 56
Epstein–Barr Virus Gene Expression and Latency Pattern in Gastric Carcinomas: A Systematic Review
Ribeiro, J., Oliveira, C., Malta, M., & de Sousa, H. M. L. (2017) · Future Oncology · doi:10.2217/fon-2016-0475 · Cited by 55
Epstein-Barr Virus Type 2 Infects T Cells and Induces B Cell Lymphomagenesis in Humanized Mice
Coleman, C. B., Lang, J., Sweet, L. A., Smith, N. A., Freed, B. M., Pan, Z., Haverkos, B. M., Pelanda, R., & Rochford, R. A. (2018) · Journal of Virology · doi:10.1128/jvi.00813-18 · Cited by 54
Barros, M. H. M., Vera‐Lozada, G., Segges, P., Hassan, R., & Niedobitek, G. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00146 · Cited by 54
BamHI‐A rightward frame 1, an Epstein–Barr virus‐encoded oncogene and immune modulator
Hoebe, E. K., Large, T. Y. S. L., Greijer, A. E., & Middeldorp, J. M. (2013) · Reviews in Medical Virology · doi:10.1002/rmv.1758 · Cited by 53
Chaganti, S., Ma, C. S., Bell, A. I., Croom-Carter, D. S. G., Hislop, A. D., Tangye, S. G., & Rickinson, A. B. (2008) · Blood · doi:10.1182/blood-2007-10-116269 · Cited by 53
Self-citationExpansion of Murine Gammaherpesvirus Latently Infected B Cells Requires T Follicular Help
Collins, C. M., & Speck, S. H. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004106 · Cited by 49
Malaria, Epstein–Barr virus infection and the pathogenesis of Burkitt's lymphoma
Mawson, A. R., & Majumdar, S. (2017) · International Journal of Cancer · doi:10.1002/ijc.30885 · Cited by 44
Virus in cultured lymphoblasts from a New Guinea Burkitt lymphoma.
Epstein, M. A., Achong, B. G., & Pope, J. H. (1967) · BMJ · doi:10.1136/bmj.2.5547.290 · Cited by 43
Li, L., Ma, B. B. Y., Chan, A. T. �., Chan, F. K. L., Murray, P. G., & Tao, Q. (2018) · Pathogens · doi:10.3390/pathogens7030063 · Cited by 34
Chronic Rhinosinusitis and the Risk of Nasopharyngeal Cancer in a Taiwanese Health Study
Tsou, Y.-A., Lin, C.-C., Tai, C.-J., Tsai, M.-H., Tsai, T.-C., & Chen, C. (2014) · American Journal of Rhinology and Allergy · doi:10.2500/ajra.2014.28.4083 · Cited by 29
Lin, K., Huang, W., Lin, C.-C., Jen, Y., Lin, C., Lo, C., & Kao, C. (2014) · Head & Neck · doi:10.1002/hed.23617 · Cited by 22
Gloghini, A., Volpi, C. C., Gualeni, A. V., Dolcetti, R., Bongarzone, I., Paoli, P. D., & Carbone, A. (2017) · Expert Review of Hematology · doi:10.1080/17474086.2017.1326815 · Cited by 11
Cited by
Epstein–Barr virus and multiple sclerosis
Soldan, S. S., & Lieberman, P. M. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00770-5 · Cited by 467
Local heroes or villains: tissue-resident memory T cells in human health and disease
Sasson, S. C., Gordon, C. L., Christo, S. N., Klenerman, P., & Mackay, L. K. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-019-0359-1 · Cited by 111
Metadata
- Authors
- Shannon-Lowe, C., & Rickinson, A.
- Venue
- Frontiers in Oncology
- Publisher
- Frontiers Media SA
- Published
- 2019-08-06
- Volume
- 9
- Pages
- 713-713
- ISSN
- 2234-943X (ISSN-L)
- OpenAlex
- W2963804040
- Cited by
- 459
- References
- 131
- FWCI
- 20.59
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.